Clinical Trials Logo

Tumor clinical trials

View clinical trials related to Tumor.

Filter by:

NCT ID: NCT04499365 Recruiting - Tumor Clinical Trials

68Ga-FAPI PET/CT in Patients With Various Types of Cancer

Start date: August 15, 2020
Phase: Early Phase 1
Study type: Interventional

To evaluate the potential usefulness of 68Ga-DOTA/NOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer.

NCT ID: NCT04495530 Completed - Cancer Clinical Trials

Information Needs Around Parenteral nUTrition in Cancer

INPUT
Start date: January 19, 2021
Phase:
Study type: Observational

This study will explore the information needs of patient's with advanced cancer, and their carers, when making a decision to commence or discontinue parenteral nutrition. Interviews will be conducted with both patients with advanced cancer, and their carers to determine the information they need to make a shared decision with the healthcare team.

NCT ID: NCT04472650 Completed - Tumor Clinical Trials

Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults

Start date: July 23, 2020
Phase: Phase 1
Study type: Interventional

The primary objective of the study was to investigate the relative bioavailability and pharmacokinetics (PK) of sitravatinib free base and malate salt capsule formulations following oral administration in healthy adults.

NCT ID: NCT04430361 Recruiting - Tumor Clinical Trials

the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Start date: September 7, 2018
Phase: Phase 2
Study type: Interventional

To compare the efficacy and safety of megestrol acetate dispersible tablets combined with 5-HT3 receptor antagonist and dexamethasone triple antiemetic regimen and 5-HT3 receptor antagonist and dexamethasone combined antiemetic regimen in the control of CINV induced by hyperemetic chemotherapy.

NCT ID: NCT04311710 Terminated - Tumor Clinical Trials

A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types

CheckMate 76U
Start date: June 25, 2020
Phase: Phase 1
Study type: Interventional

A study evaluating the drug levels of ipilimumab alone and in combination with nivolumab applied under the skin in various tumor types

NCT ID: NCT04310410 Completed - Pain Clinical Trials

Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis

PRE-FURTHER
Start date: April 11, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The PRE-FURTHER study aims to evaluate the feasibility of the combined treatment with radiotherapy and focussed ultrasound for pain palliation in patients with painful bone metastases, and to optimize the combined treatment logistics. Six to ten patients will be included according to in- and exclusion criteria.

NCT ID: NCT04307914 Recruiting - Pain Clinical Trials

Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases

FURTHER
Start date: March 10, 2020
Phase: N/A
Study type: Interventional

The FURTHER study aims to evaluate the effectiveness and cost-effectiveness of MR-HIFU (alone or in combination with EBRT) compared to EBRT alone, the standard-of-care, as a palliative treatment option to relieve CIBP. The FURTHER study consists of a multicenter, three-armed randomized controlled trial (FURTHER RCT) and a patient registry arm (FURTHER Registry), which will be performed in six hospitals in four European countries.

NCT ID: NCT04266041 Enrolling by invitation - Healthy Clinical Trials

High-density EEG in Neurological Disorders

Start date: February 9, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to use a new method of high-density electroencephalogram (HD-EEG) recording to map brain areas important for movement, sensation, language, emotion, and cognition.

NCT ID: NCT04230603 Recruiting - Inflammation Clinical Trials

Tissue Characterization With Hyperspectral Imaging (HSI)

HSIT
Start date: June 6, 2019
Phase: N/A
Study type: Interventional

Hyperspectral Imaging (HSI) is a contact free method to analyse the from the tissue reflected light in the range of 500-1000nm. Aim of the study is to identify special reflex patterns to identify special tissue

NCT ID: NCT04180046 Recruiting - Brain Tumor Clinical Trials

Utility of Primary Glioblastoma Cell Lines

Start date: June 26, 2019
Phase:
Study type: Observational

In this study, the characterization of human malignant glioma cell lines is described. After mechanical and enzymatic digestion of glioblastoma human biopsies from Neuromed IRCCS Neurosurgery patients, the investigators analyzed the established cell lines by immunohistochemistry. The investigators have already characterized 10 cell lines and results revealed that not all cell lines are positive for glial fibrillary acidic protein (GFAP), but only one was positive: the so-called COGI cell line. Moreover, the expression of Isocitrate Dehydrogenase 1(IDH1) and alpha thalassemia/mental retardation syndrome X-linked protein (ATRX) was investigated in all established cell lines. COGI cell line was also positive for IDH1R132 mutation and for ATRX. The results of characterization were summarized in table 1.